Cargando…
Measurable Residual Disease in Acute Myeloid Leukemia Using Flow Cytometry: A Review of Where We Are and Where We Are Going
The detection of measurable residual disease (MRD) has become a key investigation that plays a role in the prognostication and management of several hematologic malignancies. Acute myeloid leukemia (AML) is the most common acute leukemia in adults and the role of MRD in AML is still emerging. Progno...
Autores principales: | Dix, Caroline, Lo, Tsun-Ho, Clark, Georgina, Abadir, Edward |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357042/ https://www.ncbi.nlm.nih.gov/pubmed/32503122 http://dx.doi.org/10.3390/jcm9061714 |
Ejemplares similares
-
Genetic Abnormalities in Chronic Lymphocytic Leukemia: Where We Are and Where We Go
por: Puiggros, Anna, et al.
Publicado: (2014) -
The Clusmy Child: Where Are We and Where Are We Going?
por: Hadders-Algra, Mijna, et al.
Publicado: (2003) -
European HEPnet: where we are and where we are going
por: Carpenter, B E, et al.
Publicado: (1990) -
Iron health: where are we and where are we going?
por: Gotardo, Glória Ines Beal
Publicado: (2011) -
Hip Arthroscopy: Where We Are, and Where We Are Going
por: Park, Myung Sik, et al.
Publicado: (2015)